EMAIL DETAILS

Neil,

Thanks for spending the evening with us. I hope you enjoyed yourself
and glad you hit it off with Mike.

I wanted to follow up on your suggestion to introduce us to Mary Tolan
and Eugene Lee. Mary sounds like she'd be a valuable addition to our
investor community...we'd be happy to make room in the original Fund
for both her and Eugene (or any friend of Rosemont you think would be
valuable, for that matter). Please let me know the best way to make
this happen.

Also, Biodirection looks like a great company. I'd love to connect
Brian with Adam from Cerora when the timing is right. In fact, Brian
would be a great addition to our community of Healthcare Transformers.

Thanks and look forward to next steps.

steve
-------
Steven Krein
CEO
StartUp Health
steve@startuphealth.com
917-903-4288
@stevenkrein


On Thu, Feb 13, 2014 at 2:42 PM, Neil Callahan (Rosemont Seneca)
<ncallahan@rosemontseneca.com> wrote:
> Hey guys,
>
>
>
> It was great seeing you all yesterday. Hopefully the LaGuardia hotels are
> well stocked for today! We easily have gotten 14 inches of snow so far
> today in New Jersey and will get another 3-5 inches this evening as the rain
> changes back to snow.
>
>
>
> A great dinner - the SUH team is doing different and needed work within the
> industry. You've made awesome progress.
>
>
>
> The concussion detection company that I mentioned last night is called
> BioDirection - http://www.biodirection.com/about-us/
>
>
>
> They are in the middle of fund raise - their main focus right now is to
> impact ER protocols and to get trail in trauma centers as well as working on
> their contract manufacturing supply chain. They feel pretty good about the
> strength of their IP and the potential for market adoption. They also have
> a dementia and Alzheimer's test in the works - same technology & form
> factor - pin prick blood sample onto a slide, into a sensor to detect the
> indicative bio markers.
>
>
>
> If you'd like to learn more I can connect you with a board member and/or the
> CEO. I am under NDA, so I cannot share investor docs at this point.
>
>
>
> Safe travels home and I look forward to the continued dialog.
>
>
>
> All the best,
>
>
>
> Neil
>
>
>
>
>
>
>
>
>
> Neil Callahan
>
> Rosemont Seneca Partners
>
> 401 Greenwich Street, Suite 300
>
> New York, New York 10013
>
> 917-945-9516 (m)
>
> 866-749-8879 (f)
>
> www.rosemontsenecatech.com
>
> Confidentiality Warning: This e-mail contains information intended only for
> the use of the individual or entity named above. If the reader of this
> e-mail is not the intended recipient or the employee or agent responsible
> for delivering it to the intended recipient, any dissemination, publication
> or copying of this e-mail is strictly prohibited. The sender does not accept
> any responsibility for any loss, disruption or damage to your data or
> computer system that may occur while using data contained in, or transmitted
> with, this e-mail.If you have received this e-mail in error, please
> immediately notify us by return e-mail. Thank you
>
>